Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 Aug 24;166(3):937–949. doi: 10.1007/s10549-017-4469-0

Table 2.

Results of segregation analysis in kConFab families

Gene Group # Families Log likelihood
ABCA13 3 15 0.85 (0.32, 1.95)
ANKRD30A 3 1 0.01a (0.01a, 2.17)
APC 4 8 2.96 (0.86, 26.0a)
ARID1A 1 7 0.58 (0.05, 1.83)
ASH1L 3 5 1.24 (0.43, 2.86)
ATR 5 4 1.00 (0.17, 5.65)
BAZ1B 1 3 >26.0
C15orf42 3 5 0.74 (0.06, 2.55)
CASC5 2 2 1.49 (0.10, 8.82)
CASP8 4 1 >26.0
CDHR2 3 1 <0.01
CELSR1 5 5 0.50 (0.04, 1.73)
CEP192 5 9 1.22 (0.35, 3.39)
CHD5 2 3 0.96 (0.16, 3.28)
CHD7 1 5 1.17 (0.42, 2.87)
CHD8 1 7 2.40 (1.0, 7.32)
CHD9 1 9 0.62 (0.22, 1.34)
DGKH 3 4 1.75 (0.80, 4.57)
DLEC1 3 5 0.01a (0.01a, 3.86)
DNAH5 5 16 0.86 (0.36, 1.79)
DNMT3A 1 1 >26.0
EP400 2 5 1.65 (0.66, 4.21)
HECW1 5 3 1.41 (0.42, 4.13)
HUWE1 2 9 2.9 (0.8, 15.0)
IL17B 3 2 0.85 (0.07, 2.52)
ITPR2 3 9 1.59 (0.58, 4.61)
KDM5B 2 6 7.50 (0.24, 26.0a)
LAMA2 5 19 1.32 (0.75, 2.29)
LPHN2 5 5 1.60 (0.76, 3.33)
LRP2 5 7 0.73 (0.17, 2.06)
MAP3K1 4 6 1.16 (0.09, 16.17)
MDN1 5 11 0.01a (0.01a, 0.03)
NCOR1 1 5 1.59 (0.06, 26.0a)
NEB 3 25 0.87 (0.40, 1.65)
NELL1 5 1 1.0 (0.04, 22.26)
NET1 3 3 1.32 (0.45, 3.30)
NIPBL 2 5 1.22 (0.36, 2.86)
NOS1 2 6 0.97 (0.14, 4.39)
NOTCH1 3 7 1.82 (0.67, 5.22)
NUP210 3 6 0.58 (0.04, 2.14)
PAX5 2 3 1.52 (0.68, 3.21)
PDE4DIP 5 1 >26.0
PIK3C2G 3 1 2.78 (0.64, 25.47)
PKD1L1 5 3 0.94 (0.10, 2.61)
PLIN4 3 1 0.78 (0.05, 7.54)
PUM2 3 3 1.77 (0.38, 8.95)
RALGAPA1 5 5 1.22 (0.39, 3.29)
RBM44 3 3 0.30 (0.05, 1.02)
RIF1 1 6 0.39 (0.03, 1.52)
RNF180 3 2 0.01a (0.01a, 1.85)
SETX 3 7 1.37 (0.48, 3.80)
SLC22A5 3 3 6.66 (0.03, 26.0a)
SMG5 5 2 0.01a (0.01a, 6.44)
SPHKAP 5 2 0.67 (0.09, 4.44)
SUPT3H 3 1 0.01a (0.01a–2.3)
SYNE1 5 22 0.88 (0.45, 1.50)
SYNE2 5 9 2.14 (0.94, 5.93)
TDO2 5 1 0.01a (0.01a, 1.73)
TET2 1 3 2.21 (0.07, 26.0a)
TMEM131 3 9 1.61 (0.77, 3.78)
TPR 3 4 1.06 (0.31, 3.05)
UBAP2L 5 4 0.70 (0.15, 2.73)
UBR5 5 1 0.01a (0.01a–6.6)
USH2A 5 10 2.48 (1.11, 6.67)
XRN1 5 2 <0.01
ZNF558 3 2 1.28 (0.33, 3.22)
TOTAL 366

Group 1: genes involved in epigenetic regulation selected from the literature

Group 2: using the GO terms ‘chromatin organization’ or ‘chromatin reorganization’

Group 3: candidate genes from whole-exome sequencing of five non-BRCA1/2 families

Groups 4 and 5: breast cancer driver genes [30, 31]

a

Estimate at boundary